EMCURE PHARMACEUTICALS
Back to Balance Sheet
|
EMCURE PHARMACEUTICALS Last 5 Year Long Term Provisions History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Long Term Provisions | ₹43 Cr | ₹40 Cr | ₹42 Cr | ₹66 Cr | ₹58 Cr |
What is the latest Long Term Provisions ratio of EMCURE PHARMACEUTICALS ?
Year | Long Term Provisions |
---|---|
Mar2024 | ₹43 Cr |
Mar2023 | ₹40 Cr |
Mar2022 | ₹42 Cr |
Mar2021 | ₹66 Cr |
Mar2020 | ₹58 Cr |
How is Long Term Provisions of EMCURE PHARMACEUTICALS Trending?
Years | Long Term Provisions | % Change | |
---|---|---|---|
Mar2024 | ₹43 Cr | 9.21 | |
Mar2023 | ₹40 Cr | -5.80 | |
Mar2022 | ₹42 Cr | -36.14 | |
Mar2021 | ₹66 Cr | 12.71 | |
Mar2020 | ₹58 Cr | - |
Compare Long Term Provisions of peers of EMCURE PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
EMCURE PHARMACEUTICALS | ₹25,907.5 Cr | 0.9% | 3.2% | 0.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹406,267.0 Cr | 0.7% | 2.8% | 7.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹178,672.0 Cr | -0.8% | 3.7% | 48.6% | Stock Analytics | |
CIPLA | ₹119,713.0 Cr | -0.2% | -0.1% | -1.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹119,195.0 Cr | 3.4% | 11.2% | 17.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,999.0 Cr | 0.6% | -5.2% | -4.9% | Stock Analytics |
EMCURE PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
EMCURE PHARMACEUTICALS | 0.9% |
3.2% |
0.1% |
SENSEX | -0.9% |
0.4% |
1.4% |
You may also like the below Video Courses